HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peripheral medulloepithelioma: an immunohistochemical, ultrastructural, and cytogenetic study of a rare, chemotherapy-sensitive, pediatric tumor.

Abstract
A case of peripheral medulloepithelioma, a rapidly growing tumor involving the pelvic cavity of a 12-year-old girl, is presented. The diagnosis was supported by expression of vimentin, nestin, alpha-internexin, neurofilaments, and microtubule-associated protein 5 and by characteristic ultrastructure that included absence of cilia or microvilli. Trisomy of chromosomes 2 and 8 was the only detectable chromosomal abnormality. Combination chemotherapy resulted in complete remission. Because some of these rare tumors are sensitive to chemotherapy, their recognition and separation from other neuroectodermal tumors are advisable for better understanding of their biology and determination of optimal treatment.
AuthorsLudvik R Donner, Ikuko Teshima
JournalThe American journal of surgical pathology (Am J Surg Pathol) Vol. 27 Issue 7 Pg. 1008-12 (Jul 2003) ISSN: 0147-5185 [Print] United States
PMID12826895 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Biomarkers, Tumor
  • Neoplasm Proteins
  • Dactinomycin
  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Ifosfamide
Topics
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Biomarkers, Tumor (analysis)
  • Child
  • Chromosomes, Human, Pair 2
  • Chromosomes, Human, Pair 8
  • Cyclophosphamide (administration & dosage)
  • Dactinomycin (administration & dosage)
  • Desmosomes (ultrastructure)
  • Disease-Free Survival
  • Doxorubicin (administration & dosage)
  • Female
  • Humans
  • Ifosfamide (administration & dosage)
  • Immunohistochemistry
  • Neoplasm Proteins (analysis)
  • Neuroectodermal Tumors, Primitive (chemistry, drug therapy, genetics, pathology)
  • Pelvic Neoplasms (chemistry, drug therapy, genetics, pathology)
  • Remission Induction
  • Spectral Karyotyping
  • Treatment Outcome
  • Trisomy
  • Vincristine (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: